ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 577,49
1,09%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Rezolute Inc (RZLT)

  7. Rezolute Inc (RZLT) Actualités

RZLT Rezolute Inc

3,31
0,34 (11,45%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Rezolute Inc RZLT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,34 11,45% 3,31 00:53:39
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,06 2,98 3,38 3,31 2,97
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/4/202414:00GLOBEPhase 2 RIZE Study Sub-Analyses to be Presented at the 2024..
11/3/202422:03EDGAR2Form 8-K - Current report
11/3/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:30GLOBERezolute Reports Validation of the Potential Use of RZ358..
27/2/202414:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:00EDGAR2Form 8-K - Current report
21/2/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/2/202422:10EDGAR2Form 8-K - Current report
13/2/202422:05GLOBERezolute Reports Second Quarter Fiscal 2024 Results and..
29/1/202423:15EDGAR2Form 8-K - Current report
25/1/202418:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202418:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202418:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202414:00GLOBERezolute Expands Leadership Team with Appointment of Daron..
23/1/202414:00GLOBERezolute Receives Innovation Passport Designation from the..
14/12/202322:01EDGAR2Form 8-K - Current report
14/12/202314:00GLOBERezolute Initiates Phase 3 Clinical Study for RZ358 in..
13/12/202314:00GLOBERezolute Completes Enrollment of its Phase 2 Study in..
30/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202323:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
22/11/202322:35EDGAR2Form 8-K - Current report
17/11/202314:00GLOBERezolute to Participate in BTIG’s 3rd Annual Ophthalmology..
15/11/202315:08EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:13EDGAR2Form 8-K - Current report
13/11/202322:05GLOBERezolute Reports First Quarter Fiscal 2024 Results
18/10/202322:30EDGAR2Form 8-K - Current report
17/10/202314:00GLOBERezolute Receives Priority Medicines (PRIME) Eligibility..
13/10/202322:47EDGAR2Form 8-K - Current report
13/10/202322:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/10/202314:00GLOBERezolute Announces Further Evidence of RZ358’s Efficacy in..
14/9/202322:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/9/202322:10EDGAR2Form 8-K - Current report
14/9/202322:05GLOBERezolute Reports Full Year Fiscal 2023 Results and..
06/9/202313:00GLOBERezolute to Participate in Upcoming Investor Conferences in..
06/7/202317:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/6/202322:05GLOBERezolute to Initiate a Pivotal Phase 3 Study of RZ358 in..
11/5/202322:05GLOBERezolute Reports Third Quarter Fiscal 2023 Results and..

Dernières Valeurs Consultées

NASDAQ
RZLT
Rezolute
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés